Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis

AT Cohen, MB Wagner, MS Mohamed - The American journal of surgery, 1997 - Elsevier
BACKGROUND: Patients undergoing major abdominal surgery are at risk of both bleeding
and thrombotic complications and usually receive heparin thromboprophylaxis. PATIENTS …

Annexin 2 and hemorrhagic disorder in vascular intimal carcinomatosis

S Madoiwa, T Someya, M Hironaka, H Kobayashi… - Thrombosis research, 2007 - Elsevier
Vascular intimal carcinomatosis refers to a characteristic tumor proliferation on vascular
intima that replaces normal endothelium. This pathological event of unknown cause is quite …

Clinical and prognostic significance of coagulation assays in melanoma

F Tas, R Ciftci, L Kilic, E Bilgin, S Keskin, F Sen… - Melanoma …, 2012 - journals.lww.com
The activation of coagulation and fibrinolysis is frequently found among cancer patients.
Such tumors are considered to be associated with a higher risk of invasion, metastases, and …

[HTML][HTML] Endothelial cell perturbation and disseminated intravascular coagulation

N Semeraro, M Colucci - Madame Curie Bioscience Database …, 2013 - ncbi.nlm.nih.gov
It has long been recognized that the vascular endothelium is a major target of bacterial
endotoxin and of a variety of microorganisms, and that damage to endothelial cells (ECs) is …

Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders

A Tripodi, PM Mannucci… - British journal of …, 1993 - Wiley Online Library
Hypercoagulability can be defined as a condition of procoagulant imbalance due to
heightened enzymatic activation of coagulation zymogens, but with no laboratory evidence …

Anticarcinogenic activities of naturally occurring cysteine proteinase inhibitors

R Colella, AF Chambers, DT Denhardt - Protease Inhibitors as Cancer …, 1993 - Springer
Proteases and their respective inhibitors are found in almost every biological system where
proteolysis occurs. Examples of such systems include the processing of proteins during …

Quality control for HPLC assay and surrogate end point biomarkers from the fenretinide (4‐HPR) breast cancer prevention trial

F Formelli - Journal of Cellular Biochemistry, 2000 - Wiley Online Library
Abstract The Fenretinide (4‐HPR) Breast Cancer Study is a randomized multicenter clinical
trial designed to evaluate the effectiveness of the synthetic retinoid 4‐HPR, at a dose of 200 …

Plasminogen activators and plasminogen activator inhibitor in portal blood from patients with and without gastric malignancy

HB Rahr, JV Sørensen, JF Larsen… - Scandinavian journal …, 1996 - Taylor & Francis
Background: Plasminogen activators (PA) may be released by the gut and eliminated by the
liver. Patients with liver disorders or malignancy often have abnormal plasma levels of PAs …

Melanoma associated with subacute primitive fibrinolysis

S Blaise, M Rumeau‐Trividic, V Le Brun… - Journal of the …, 2005 - Wiley Online Library
Background Surgery is the first treatment of a pigmented skin lesion when a melanoma is
suspected. This excision is most of the time realized by the dermatologist as well as the …

Endothelial Cell PAI-1 Production — Modulation by Malignant Cells in vitro

LW Zhen, MC Ling, N Wickham - Vascular Endothelium: Pharmacologic …, 1998 - Springer
Abstract Plasminogen activator inhibitor-1 (PAI-1) is a single chain glycoprotein of
approximately 50,000 Daltons which is synthesized by endothelial cells and hepatocytes. It …